Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cystic fibrosis
Marcus Mall, Pierre‐Régis Burgel, Carlo Castellani, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 25

Showing 25 citing articles:

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Jordana E. Hoppe, Ajay S. Kasi, Jessica E. Pittman, et al.
The Lancet Respiratory Medicine (2025)
Open Access | Times Cited: 10
Cystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor
Vito Terlizzi, Miquéias Lopes‐Pacheco
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access | Times Cited: 1
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis
Alessia Finotti, Roberto Gambari
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 3-3
Open Access
Psychometric validation of the Cystic Fibrosis Impact Questionnaire (CF-IQ): A patient-reported outcome assessing impacts of cystic fibrosis
Daniel Sánchez Serrano, Alyssa Uzumcu, Maya Gerstein, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317775-e0317775
Open Access
Airways and Inhalational Lung Disease
Grazia M. Cereghetti, Andreas Christe
IDKD Springer series (2025), pp. 1-11
Open Access
Intestinal current measurement detects age-dependent differences in CFTR function in rectal epithelium
Simon Y. Graeber, Olaf Sommerburg, Yin Yu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
How Effectively Can Oxidative Stress and Inflammation Be Reversed When CFTR Function Is Pharmacologically Improved?
Valeria Rachela Villella, Alice Castaldo, Filippo Scialò, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 310-310
Open Access
Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations
Francesca Lucca, Sonia Volpi, Mirco Ros, et al.
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Cystic fibrosis–related kidney disease—emerging morbidity and disease modifier
Merrill Hart, Manish Kumar, Himanshu Ballav Goswami, et al.
Pediatric Nephrology (2025)
Open Access
The established chest MRI score for cystic fibrosis can be applied to contrast agent-free matrix pencil decomposition functional MRI: a multireader analysis
Eva Steinke, Grzegorz Bauman, Ingo G. Steffen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
A retrospective cohort study of children diagnosed with CF after implementation of a newborn screening program in Turkey
Handan Kekeç, Tuğba Şişmanlar Eyüboğlu, Ayşe Tana Aslan, et al.
Respiratory Medicine (2025), pp. 108047-108047
Closed Access
Cystic fibrosis at a glance: from disease mechanism to therapy
Kasper Gryspeert, Laudonia L Dipalo, Ana Lúcia Da Silva Cunha, et al.
Trends in Molecular Medicine (2025)
Closed Access
Tracheal Diverticula in People with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: An Italian Multicenter Retrospective Study
Laura Venditto, Antonella Tosco, Angela Sepe, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2320-2320
Open Access
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management
Giuseppe Fabio Parisi, Vito Terlizzi, Sara Manti, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 402-402
Open Access
Exploration of Olfaction and ChiPSO in Pediatric Cystic Fibrosis
Tiana M. Saak, Jeremy P. Tervo, Ben Moore, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2583-2583
Open Access
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study
Jerry A. Nick, Stacey L. Martiniano, Valerie K. Lovell, et al.
Journal of Cystic Fibrosis (2025)
Open Access
Establishing a Xanthan Gum–Locust Bean Gum Mucus Mimic for Cystic Fibrosis Models: Yield Stress and Viscoelasticity Analysis
Rameen Taherzadeh, Nathan A. Wood, Zhijian Pei, et al.
Biomimetics (2025) Vol. 10, Iss. 4, pp. 247-247
Open Access
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators
Burkhard Tümmler, Sophia T. Pallenberg, Anna‐Maria Dittrich, et al.
Molecular and Cellular Pediatrics (2025) Vol. 12, Iss. 1
Open Access
Results of Comparative Effectiveness of Pathogenetic Therapy with CFTR Modulators in Children with Cystic Fibrosis
Yu. O. Vasenyova, Irina V. Vakhlova, O. Yu. Averyanov
Ural Medical Journal (2025) Vol. 24, Iss. 2, pp. 95-108
Closed Access
Same‐Day Repeatability and 28‐Day Reproducibility of Xenon MRI Ventilation in Children With Cystic Fibrosis in a Multi‐Site Trial
Laura L. Walkup, David J. Roach, Joseph W. Plummer, et al.
Journal of Magnetic Resonance Imaging (2024)
Open Access | Times Cited: 2
Study of the genetic and molecular epidemiology of cystic fibrosis based on the patient registry for planning targeted therapy in Russian Federation
E. Kondratyeva, Y. Melyanovskaya, V. Sherman, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Antibiotic treatment of bacterial lung infections in cystic fibrosis
Giovanni Taccetti, Vito Terlizzi, Silvia Campana, et al.
European Journal of Pediatrics (2024) Vol. 184, Iss. 1
Open Access | Times Cited: 1
Opportunistic Screening for Low Bone Mineral Density in Adults with Cystic Fibrosis Using Low-Dose Computed Tomography of the Chest with Artificial Intelligence
Matthias Welsner, Henning Navel, René Hosch, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5961-5961
Open Access
How many functioning ciliated airway epithelial cells are necessary for effective mucociliary clearance?
Ruth M. Urbantat, Marcus Mall
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401573-2401573
Closed Access
Systemic effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulators on the blood proteome
Kerstin Fentker, Marieluise Kirchner, Matthias Ziehm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top